Published in Am Heart J on February 21, 2008
Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction. Heart Vessels (2010) 0.96
Impact of mitral regurgitation on exercise capacity and clinical outcomes in patients with ischemic left ventricular dysfunction. Am J Cardiol (2011) 0.82
Mitral regurgitation during exercise in patients with left ventricular systolic dysfunction. Am Heart J (2008) 0.75
PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab (2007) 7.19
Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med (2003) 5.33
Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med (2012) 4.37
Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum (2005) 3.44
CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res (2005) 3.03
STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J (2007) 3.03
Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med (2012) 2.88
Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet (2011) 2.88
Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways. Circ Res (2011) 2.60
Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol (2010) 2.52
In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates? J Thorac Cardiovasc Surg (2007) 2.13
Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther (2008) 2.13
Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients. Eur Heart J (2007) 2.12
Automated 3D analysis of pre-procedural MDCT to predict annulus plane angulation and C-arm positioning: benefit on procedural outcome in patients referred for TAVR. JACC Cardiovasc Imaging (2013) 2.10
Pivotal role of bedside Doppler echocardiography in the assessment of patients with acute heart failure and mitral regurgitation. Cardiology (2009) 2.03
Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J (2004) 1.98
Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. Eur Heart J (2011) 1.93
Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group). Am J Cardiol (2006) 1.87
Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). Am J Cardiol (2010) 1.78
Liver X receptor activation stimulates iron export in human alternative macrophages. Circ Res (2013) 1.66
Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. J Am Coll Cardiol (2002) 1.66
High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Eur Heart J (2005) 1.64
Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur Radiol (2008) 1.63
Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res (2014) 1.60
Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction. Eur Heart J (2004) 1.59
Right ventricular systolic function in organic mitral regurgitation: impact of biventricular impairment. Circulation (2013) 1.58
Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol (2005) 1.58
Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction. Circulation (2008) 1.56
Inferior vena cava agenesis and deep vein thrombosis: 10 patients and review of the literature. Vasc Med (2010) 1.56
Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial. Am Heart J (2012) 1.55
Functional decline in elderly patients presenting with acute coronary syndromes: impact on midterm outcome. Arch Cardiovasc Dis (2009) 1.54
Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure. Am Heart J (2005) 1.53
Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Eur Heart J (2005) 1.52
Atherosclerotic-like process in aortic stenosis: activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration. Atherosclerosis (2010) 1.52
The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients. Am Heart J (2006) 1.48
Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor. J Thorac Cardiovasc Surg (2006) 1.46
Transient left ventricular basal dysfunction without coronary stenosis in acute cerebral disorders: a novel heart syndrome (inverted Takotsubo). Echocardiography (2005) 1.46
Comparison of blood activation in the wound, active vent, and cardiopulmonary bypass circuit. Ann Thorac Surg (2008) 1.45
Mid-ventricular ballooning heart syndrome. Echocardiography (2007) 1.45
Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry. Eur J Echocardiogr (2010) 1.43
B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol (2004) 1.42
Aspirin does not adversely affect survival in patients with stable congestive heart failure treated with Angiotensin-converting enzyme inhibitors. Chest (2003) 1.42
Frequency of drug-induced valvular heart disease in patients previously exposd to benfluorex: a multicentre prospective study. Eur Heart J (2013) 1.42
[Benfluorex and valvular heart disease]. Presse Med (2011) 1.41
Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations. Hum Mol Genet (2007) 1.40
Long-term risk and predictors of cardiovascular death in stable coronary artery disease: the CORONOR study. Coron Artery Dis (2017) 1.38
An unusual case of papillary fibroelastoma "invading" the mitral valve. J Thorac Cardiovasc Surg (2006) 1.38
Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol (2002) 1.35
Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum (2011) 1.35
Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells. Circ Res (2008) 1.31
Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest. J Card Fail (2008) 1.26